A case of treatment refractory hyperemesis gravidarum in a patient with comorbid anxiety, treated successfully with adjunctive gabapentin: A review and the potential role of neurogastroentereology in understanding its pathogenesis and treatment

Innovations in Clinical Neuroscience

Volumn 9, Issue 11-12, 2012, Pages 31-38

  Spiegel, David R ^a   Webb, Kathryn ^a  

^a EASTERN VIRGINIA MEDICAL SCHOOL   (United States)

Author keywords

Gabapentin; Hyperemesis gravidarum; Neurogastroenterology

Indexed keywords

GABAPENTIN; HEMOGLOBIN; ONDANSETRON; PROMETHAZINE;

ABNORMAL LABORATORY RESULT; ADULT; ALCOHOL CONSUMPTION; ANXIETY DISORDER; ARTICLE; CASE REPORT; CLINICAL FEATURE; COMORBIDITY; DRUG DOSE INCREASE; FEMALE; FOLLOW UP; GINGER; HEMATOCRIT; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPEREMESIS GRAVIDARUM; LEUKOCYTE COUNT; MEDICAL HISTORY; NAUSEA AND VOMITING; PLACENTA PREVIA; PREMATURE LABOR; SPONTANEOUS ABORTION; TREATMENT OUTCOME; VAGINA BLEEDING;

EID: 84874287413     PISSN: 21588333     EISSN: 21588341     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Sonkusare S. The clinical management of hyperemesis gravidarum. Arch Gynecol Obstet. 2011 Jun;283(6):1183-1192.
2. Ismail SK, Kenny L. Review on hyperemesis gravidarum. Best Pract Res Clin Gastroenterol. 2007;21(5):755-769.
3. Niebyl JR. Clinical practice. Nausea and vomiting in pregnancy. N Engl J Med. 2010;363(16):1544-1550.
4. Koren G, Boskovic R, Hard M, et al. Motherisk-PUQE (pregnancy-unique quantification of emesis and nausea) scoring system for nausea and vomiting of pregnancy. Am J Obstet Gynecol. 2002;186(5 Suppl Understanding):S228-S231.
5. Hamilton, M. The Assessment of Anxiety States by Rating. Br J Med Psychol. 1959;32:50-55.
6. Apgar V. A proposal for a new method of evaluation of the newborn infant. Curr Res Anesth Analg. 1953;32:260-267.
7. Wegrzyniak LJ, Repke JT, Ural SH. Treatment of hyperemesis gravidarum. Rev Obstet Gynecol. 2012;5(2):78-84.
8. Guttuso T Jr, Robinson LK, Amankwah KS. Gabapentin use in hyperemesis gravidarum: a pilot study. Early Hum Dev. 2010;86(1):65-66.
9. Reimers A, Brodtkorb E. Second-generation antiepileptic drugs and pregnancy: a guide for clinicians. Expert Rev Neurother. 2012;12(6):707-717.
10. Grundy D, Al-Chaer ED, Aziz Q, et al. Fundamentals of neurogastroenterology: basic science. Gastroenterology. 2006;130(5):1391-1411.
11. Van Oudenhove L, Demyttenaere K, Tack J, Aziz Q. Central nervous system involvement in functional gastrointestinal disorders. Best Pract Res Clin Gastroenterol. 2004;18(4):663-680.
12. Browning KN, Travagli RA. Plasticity of vagal brainstem circuits in the control of gastric function. Neurogastroenterol Motil. 2010;22(11):1154-1163.
13. Shah S, Nathan L, Singh R, et al. E2 and not P4 increases NO release from NANC nerves of the gastrointestinal tract: implications in pregnancy. Am J Physiol Regul Integr Comp Physiol. 2001;280(5):R1546-1554.
14. Maes BD, Spitz B, Ghoos YF, et al. Gastric emptying in hyperemesis gravidarum and non-dyspeptic pregnancy. Aliment Pharmacol Ther. 1999;13(2):237-243.
15. Wood JD. Neuropathophysiology of functional gastrointestinal disorders. World J Gastroenterol. 2007;13(9):1313-1332.
16. Owyang C, Hasler WL. Physiology and pathophysiology of the interstitial cells of Cajal: from bench to bedside. VI. Pathogenesis and therapeutic approaches to human gastric dysrhythmias. Am J Physiol Gastrointest Liver Physiol. 2002;283(1):G8-G15.
17. Grundy D, Al-Chaer ED, Aziz Q, et al. Fundamentals of neurogastroenterology: basic science. Gastroenterology. 2006;130(5):1391-1411.
18. Walsh JW, Hasler WL, Nugent CE, Owyang C. Progesterone and estrogen are potential mediators of gastric slow-wave dysrhythmias in nausea of pregnancy. Am J Physiol. 1996;270(3 Pt 1):G506-G514.
19. Gale JD, Houghton LA. Alpha 2 delta ligands, gabapentin and pregabalin: What is the evidence for potential use of these ligands in irritable bowel syndrome. Front Pharmacol. 2011;2:28.
20. Keld R, Kinsey L, Athwal V, Lal S. Pathogenesis, investigation and dietary and medical management of gastroparesis. J Hum Nutr Diet. 2011 Oct;24(5):421-430.
21. Kim TW, Koh SD, Ordög T, et al. Muscarinic regulation of pacemaker frequency in murine gastric interstitial cells of Cajal. J Physiol. 2003 Jan 15;546(Pt 2):415-425.
22. Takaki M. Gut pacemaker cells: the interstitial cells of Cajal (ICC). J Smooth Muscle Res. 2003;39(5):137-161.
23. Tzellos TG, Papazisis G, Toulis KA, et al. Alpha2delta ligands gabapentin and pregabalin: future implications in daily clinical practice. Hippokratia. 2010;14(2):71-75.
24. Kim DR, Connolly KR, Cristancho P, et al. Psychiatric consultation of patients with hyperemesis gravidarum. Arch Womens Ment Health. 2009;12(2):61-67.
25. Uguz F, Gezginc K, Kayhan F et al. Is hyperemesis gravidarum associated with mood, anxiety and personality disorders: a case-control study. Gen Hosp Psychiatry. 2012;34(4):398-402.
26. Jahangiri F, Hirshfeld-Cytron J, Goldman K, et al. Correlation between depression, anxiety, and nausea and vomiting during pregnancy in an in-vitro fertilization population: a pilot study. J Psychosom Obstet Gynaecol. 2011;32(3):113-118.
27. Lorena SL, Tinois E, Brunetto SQ, et al. Gastric emptying and intragastric distribution of a solid meal in functional dyspepsia: influence of gender and anxiety. J Clin Gastroenterol. 2004;38(3):230-236.
28. Matthews A, Dowswell T, Haas DM, et al. Interventions for nausea and vomiting in early pregnancy. Coch Data Syst Rev. 2010;(9):CD007575.
29. ACOG (American College of Obstetrics and Gynecology) practice bulletin: nausea and vomiting of pregnancy. Obstet Gynecol 2004; 103:803-814.
30. Clark SM, Costantine MM, Hankins GD. Review of NVP and HG and early pharmacotherapeutic intervention. Obstet Gynecol Int. 2012; 2012:252676. Epub 2011 Nov 24.
31. Olsen JC, Keng JA, Clark JA. Frequency of adverse reactions to prochlorperazine in the ED. Am J Emerg Med. 2000;18(5):609-611.
32. Rao AS, Camilleri M. Review article: metoclopramide and tardive dyskinesia. Aliment Pharmacol Ther. 2010;31(1):11-19.
33. Bondok RS, El Sharnouby NM, Eid HE, Abd Elmaksoud AM. Pulsed steroid therapy is an effective treatment for intractable hyperemesis gravidarum. Crit Care Med. 2006;34(11):2781-2783.
34. Ebrahimi N, Maltepe C, Einarson A. Optimal management of nausea and vomiting of pregnancy. Int J Womens Health. 2010;2:241-248.
35. Veenendaal M, van Abeelen A, Painter R, et al. Consequences of hyperemesis gravidarum for offspring: a systematic review and meta-analysis. BJOG 2011;118:1302-1313.
36. Kuru O, Sen S, Akbay O, et al. Outcomes of pregnancies complicated by hyperemesis gravidarum. Arch Gynecol Obstet. 2012;285(6):1517-1521.
37. Ditto A, Morgante G, la Marca A et al. Evaluation of treatment of hyperemesis gravidarum using parenteral fluid with or without diazepam. A randomized study. Gynecol Obstet Invest. 1999;48(4):232-236.
38. Tasci Y, Demir B, Dilbaz S, et al. Use of diazepam for hyperemesis gravidarum. J Matern Fetal Neonatal Med. 2009;22(4):353-356.
39. Drug Information Online. Diazepam. http://www.drugs.com/diazepam.html. Accessed December 1, 2012.
40. Jueckstock JK, Kaestner R, Mylonas I. Managing hyperemesis gravidarum: a multimodal challenge. BMC Med. 2010;8
41. Montouris G. Gabapentin exposure in human pregnancy: results from the Gabapentin Pregnancy Registry. Epilepsy Behav. 2003;4(3):310-317.
42. Park-Wyllie L, Mazzotta P, Pastuszak A, et al. Birth defects after maternal exposure to corticosteroids: prospective cohort study and meta-analysis of epidemiological studies. Teratology. 2000;62(6):385-392.